SPY326.52+2.56 0.79%
DIA264.35+1.07 0.41%
IXIC10,745.28+157.46 1.49%
News
BNTX
--
0.00%
--
These Coronavirus Vaccine Makers Are Winning the Money Game So Far
MotleyFool.com · 2d ago
5 Coronavirus Vaccines With Huge Operation Warp Speed Deals
MotleyFool.com · 2d ago
Here's How to Build the Safest But Most Promising Coronavirus Portfolio
MotleyFool.com · 2d ago
Better Coronavirus Stock: BioNTech or GlaxoSmithKline?
MotleyFool.com · 3d ago
Regeneron teams up with BioNTech in melanoma
Seeking Alpha · 3d ago
Glaxo and Sanofi Will Sell 100 Million Covid-19 Vaccine Doses to the U.S. for Less Than $10.50 Each
The European drugmakers (SAN)and (GSK)announced on Friday morning a $2.1 billion deal with the U.S. government for 100 million doses of the Covid-19 vaccine the two companies are developing. The companies said that “more than half” of the $2.1 billion was m
Barrons.com · 3d ago
Why Pfizer Could Be a Bigger Coronavirus Winner Than Moderna
Moderna had a head start in advancing its COVID-19 vaccine into clinical testing. But Pfizer is ahead in some important ways.
Motley Fool · 3d ago
Pfizer, BioNTech to supply 120 million doses of coronavirus vaccine to Japan
Reuters · 3d ago
Pfizer and BioNTech to Supply Japan with 120 Million Doses of Their BNT162 mRNA-Based Vaccine Candidate
* Supply of 120 million doses to be provided in the first half of 2021, subject to regulatory approval * Agreement is part of Pfizer’s and BioNTech’s global commitment to help address the pandemic * Pfizer and BioNTech began a Phase 2b/3 safety and e
GlobeNewswire · 3d ago
BioNTech Announces Strategic Collaboration with Regeneron to Advance FixVac and Libtayo® (cemiplimab) Combination in Melanoma
* BioNTech and Regeneron plan to jointly conduct a randomized Phase 2 study combining BNT111 FixVac and Libtayo for the treatment of melanoma that has progressed after prior PD-1 blockade * Combines two immunotherapies with complementary mechanisms of action
GlobeNewswire · 3d ago
Pfizer Covid-19 Vaccine Sales Could Hit $15 Billion
GuruFocus News · 3d ago
Coronavirus update: Sun Belt surge fans recovery fears; Trump ally Herman Cain dies
Grim jobless and economic growth data on Thursday underscored how badly the coronavirus pandemic has damaged the world’s largest economy, as still rising COVID-19 diagnoses amplify concerns for the recovery.
Yahoo Finance · 3d ago
The Daily Biotech Pulse: Bristol-Myers, Bluebird Bio Resubmit Multiple Myeloma Drug BLA, FSD To Close Medicinal Cannabis Business, Hologic's Blowout Quarter
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 29) * Abbott Laboratories (NYSE: ABT) * ABIOMED, Inc. (NASDAQ: ABMD) * Adamis Pharmaceuticals Corp (NASDAQ: ADMP) * Annexon Inc (NASDAQ: ANNX) (went public Friday) * Bio-Rad Laboratories, Inc. C
Benzinga · 4d ago
The Daily Biotech Pulse: Bristol-Myers, Bluebird Bio Resubmit Multiple Myeloma Drug BLA, FSD To Close Medicinal Cannabis Business, Hologic's Blowout Quarter
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 29)
Benzinga · 4d ago
BioNTech Publishes Data from mRNA-based BNT111 FixVac Melanoma Trial in Nature; Shows Efficacy Analysis in Subset of 42 Cpi-experienced Metastatic Melanoma Patients Shows That BNT111 Mediates Durable Responses
BioNTech SE (NASDAQ: BNTX) announced today the publication of interim Phase 1 data for the Company's FixVac cancer vaccine program BNT111 in the journal Nature.
Benzinga · 4d ago
BioNTech Publishes Data from mRNA-based BNT111 FixVac Melanoma Trial in Nature
* Preliminary Phase 1 results from Lipo-MERIT trial with data from 89 patients highlight favorable tolerability profile of BNT111 in advanced melanoma patients * Efficacy analysis in a subset of 42 checkpoint-inhibitor (CPI)-experienced metastatic melanoma pa
GlobeNewswire · 4d ago
BioNTech cancer vaccine shows promising action in early-stage study
Seeking Alpha · 4d ago
Should Moderna Be Your Next Coronavirus Stock?
MotleyFool.com · 4d ago
Pfizer And BioNTech Pick A Vaccine Candidate
Seeking Alpha · 4d ago
Glaxo and Sanofi to Provide Covid-19 Vaccine to the U.K. ‘We Don’t Expect to Profit.’
A rift is opening between drug companies that say they plan to profit off their vaccines and those that won’t.
Barrons.com · 4d ago